Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection

被引:104
|
作者
Segal, BH
Barnhart, LA
Anderson, VL
Walsh, TJ
Malech, HL
Holland, SM
机构
[1] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA
[2] Roswell Pk Canc Inst, Dept Med, Div Infect Dis, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Immunol, Div Infect Dis, Buffalo, NY 14263 USA
[4] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[5] NCI, Immunocompromised Host Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1086/430068
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic granulomatous disease (CGD) is characterized by life-threatening bacterial and fungal infections. Treatment with posaconazole led to a complete response in 7 of 8 patients with CGD with invasive mold infections ( 7 proven cases and 1 possible case) after failure or intolerance of treatment with standard antifungal agents. In this preliminary study, salvage treatment with posaconazole was safe and effective.
引用
收藏
页码:1684 / 1688
页数:5
相关论文
共 50 条
  • [11] Invasive Fungal Infection in Primary Immunodeficiencies Other Than Chronic Granulomatous Disease
    Garraffo A.
    Pilmis B.
    Toubiana J.
    Puel A.
    Mahlaoui N.
    Blanche S.
    Lortholary O.
    Lanternier F.
    Current Fungal Infection Reports, 2017, 11 (1) : 25 - 34
  • [12] Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment
    Hachem, R. Y.
    Langston, A. A.
    Graybill, J. R.
    Perfect, J. R.
    Pedicone, L. D.
    Patino, H.
    Raad, I. I.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1386 - 1391
  • [13] Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
    Allegra, Sarah
    Fatiguso, Giovanna
    De Francia, Silvia
    Favata, Fabio
    Pirro, Elisa
    Carcieri, Chiara
    De Nicolo, Amedeo
    Cusato, Jessica
    Di Perri, Giovanni
    D'Avolio, Antonio
    BIOMEDICINES, 2017, 5 (04)
  • [14] Posaconazole plasma concentrations in juvenile patients with invasive fungal infection
    Krishna, Gopal
    Sansone-Parsons, Angela
    Martinho, Monika
    Kantesaria, Lhavna
    Pedicone, Lisa
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) : 812 - 818
  • [15] Invasive fungal infections in the child with chronic granulomatous disease
    Warris A.
    Henriet S.S.V.
    Current Fungal Infection Reports, 2014, 8 (1) : 37 - 44
  • [16] Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection
    Sole, Amparo
    Garcia-Robles, Ana A.
    Jorda, Carlos
    Cases Viedma, Enrique
    Mancheno, Nuria
    Luis Poveda-Andres, Jose
    Pablo Reig Mezquida, Juan
    Peman, Javier
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (02) : 504 - 509
  • [17] Rhizopus Oryzae Skin Infection Treated With Posaconazole in a Boy With Chronic Granulomatous Disease
    Wildenbeest, Joanne G.
    Oomen, Matthijs W.
    Bruggemann, Roger J.
    de Boer, Martin
    Bijleveld, Yuma
    van den Berg, J. Merlijn
    Kuijpers, Taco W.
    Pajkrt, Dasja
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (06) : 578 - 578
  • [18] Utilization of posaconazole oral suspension or delayed-released tablet salvage treatment for invasive fungal infection
    Kim, Jong Hun
    Benefield, Russell J.
    Ditolla, Kali
    MYCOSES, 2016, 59 (11) : 726 - 733
  • [19] Chronic Granulomatous Invasive Fungal Sinusitis in Patients With Immunocompetence: A Review
    Rupa, Vedantam
    Peter, Jayanthi
    Michael, Joy Sarojini
    Thomas, Meera
    Irodi, Aparna
    Rajshekhar, Vedantam
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 168 (04) : 669 - 680
  • [20] Posaconazole for treatment of refractory invasive fungal disease
    Notheis, G.
    Tarani, L.
    Costantino, F.
    Jansson, A.
    Rosenecker, J.
    Friederici, D.
    Belohradsky, B. H.
    Reinhardt, D.
    Seger, R.
    v. Schweinitz, D.
    Wintergerst, Uwe
    MYCOSES, 2006, 49 : 37 - 41